Literature DB >> 8552747

Strategies of research for a vaccine against AIDS.

M Essex1.   

Abstract

Retroviruses replicate by inserting their proviral DNA into host cell chromosomes, usually in cells of the immune system. Nevertheless, an efficacious and safe subunit recombinant vaccine has been prepared against the feline leukemia retrovirus of cats. Because of high rates of morbidity and mortality, particularly in the developing world, the development of a vaccine against human immunodeficiency virus type I (HIV-I) has become very important. The very high rate of mutation or variation of lentiviruses, such as HIV-I, makes a vaccine against this virus particularly difficult. Active research must be encouraged to design a modified envelope vaccine molecule of gp120 subtype E or C for trials in appropriate developing country settings.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8552747

Source DB:  PubMed          Journal:  Hist Philos Life Sci        ISSN: 0391-9714            Impact factor:   1.205


  2 in total

1.  Retroviral mutation rates and A-to-G hypermutations during different stages of retroviral replication.

Authors:  T Kim; R A Mudry; C A Rexrode; V K Pathak
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

2.  The antiretrovirus drug 3'-azido-3'-deoxythymidine increases the retrovirus mutation rate.

Authors:  J G Julias; T Kim; G Arnold; V K Pathak
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.